Cargando…
The First Korean Case of HDR Syndrome Confirmed by Clinical and Molecular Investigation
Hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome is a rare condition inherited as autosomal dominant trait and characterized by hypoparathyroidism, sensorineural deafness, and renal dysplasia. HDR syndrome is caused by haploinsufficiency of the GATA3 gene located on chromosome 10p15....
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276771/ https://www.ncbi.nlm.nih.gov/pubmed/25510779 http://dx.doi.org/10.3349/ymj.2015.56.1.300 |
_version_ | 1782350292576108544 |
---|---|
author | Cheon, Chong-Kun Kim, Gu-Hwan Yoo, Han-Wook |
author_facet | Cheon, Chong-Kun Kim, Gu-Hwan Yoo, Han-Wook |
author_sort | Cheon, Chong-Kun |
collection | PubMed |
description | Hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome is a rare condition inherited as autosomal dominant trait and characterized by hypoparathyroidism, sensorineural deafness, and renal dysplasia. HDR syndrome is caused by haploinsufficiency of the GATA3 gene located on chromosome 10p15. Here, we report the case of a 32-day-old Korean male with HDR syndrome. He was presented due to repeated seizures over previous 3 days. The patient was born after 40 weeks of gestation with birth weight of 2930 g, and was the first-born baby of healthy Korean parents. Hypoparathyroidism was first noticed due to seizure. A multicystic left dysplastic kidney and vesicoureteral reflux were detected by ultrasound after birth. Auditory brainstem response (ABR) testing revealed that the patient had moderate sensorineural deafness, with hearing losses of 80 dB at the mid and higher frequencies for both ears. Echocardiography finding revealed secundum atrial septal deftect. Based on biochemical results and clinical findings, a presumptive diagnosis of HDR syndrome was made. GATA3 mutation analysis identified a heterozygous deletion, c.153del (p.Phe51Leufs(*)144) in exon 1 causing a frameshift mutation, which is a novel de novo mutation. Therefore, we suggest that HDR syndrome should be considered in the differential diagnosis in symptomatic or asymptomatic patients with hypoparathyroidism, and that renal ultrasound or ABR testing be performed to prevent a missed diagnosis. This is the first report on Korean patient with confirmed HDR syndrome with novel mutation. |
format | Online Article Text |
id | pubmed-4276771 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Yonsei University College of Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-42767712015-01-01 The First Korean Case of HDR Syndrome Confirmed by Clinical and Molecular Investigation Cheon, Chong-Kun Kim, Gu-Hwan Yoo, Han-Wook Yonsei Med J Case Report Hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome is a rare condition inherited as autosomal dominant trait and characterized by hypoparathyroidism, sensorineural deafness, and renal dysplasia. HDR syndrome is caused by haploinsufficiency of the GATA3 gene located on chromosome 10p15. Here, we report the case of a 32-day-old Korean male with HDR syndrome. He was presented due to repeated seizures over previous 3 days. The patient was born after 40 weeks of gestation with birth weight of 2930 g, and was the first-born baby of healthy Korean parents. Hypoparathyroidism was first noticed due to seizure. A multicystic left dysplastic kidney and vesicoureteral reflux were detected by ultrasound after birth. Auditory brainstem response (ABR) testing revealed that the patient had moderate sensorineural deafness, with hearing losses of 80 dB at the mid and higher frequencies for both ears. Echocardiography finding revealed secundum atrial septal deftect. Based on biochemical results and clinical findings, a presumptive diagnosis of HDR syndrome was made. GATA3 mutation analysis identified a heterozygous deletion, c.153del (p.Phe51Leufs(*)144) in exon 1 causing a frameshift mutation, which is a novel de novo mutation. Therefore, we suggest that HDR syndrome should be considered in the differential diagnosis in symptomatic or asymptomatic patients with hypoparathyroidism, and that renal ultrasound or ABR testing be performed to prevent a missed diagnosis. This is the first report on Korean patient with confirmed HDR syndrome with novel mutation. Yonsei University College of Medicine 2015-01-01 2014-12-10 /pmc/articles/PMC4276771/ /pubmed/25510779 http://dx.doi.org/10.3349/ymj.2015.56.1.300 Text en © Copyright: Yonsei University College of Medicine 2015 http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Cheon, Chong-Kun Kim, Gu-Hwan Yoo, Han-Wook The First Korean Case of HDR Syndrome Confirmed by Clinical and Molecular Investigation |
title | The First Korean Case of HDR Syndrome Confirmed by Clinical and Molecular Investigation |
title_full | The First Korean Case of HDR Syndrome Confirmed by Clinical and Molecular Investigation |
title_fullStr | The First Korean Case of HDR Syndrome Confirmed by Clinical and Molecular Investigation |
title_full_unstemmed | The First Korean Case of HDR Syndrome Confirmed by Clinical and Molecular Investigation |
title_short | The First Korean Case of HDR Syndrome Confirmed by Clinical and Molecular Investigation |
title_sort | first korean case of hdr syndrome confirmed by clinical and molecular investigation |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276771/ https://www.ncbi.nlm.nih.gov/pubmed/25510779 http://dx.doi.org/10.3349/ymj.2015.56.1.300 |
work_keys_str_mv | AT cheonchongkun thefirstkoreancaseofhdrsyndromeconfirmedbyclinicalandmolecularinvestigation AT kimguhwan thefirstkoreancaseofhdrsyndromeconfirmedbyclinicalandmolecularinvestigation AT yoohanwook thefirstkoreancaseofhdrsyndromeconfirmedbyclinicalandmolecularinvestigation AT cheonchongkun firstkoreancaseofhdrsyndromeconfirmedbyclinicalandmolecularinvestigation AT kimguhwan firstkoreancaseofhdrsyndromeconfirmedbyclinicalandmolecularinvestigation AT yoohanwook firstkoreancaseofhdrsyndromeconfirmedbyclinicalandmolecularinvestigation |